Genmab A/S (Nasdaq: GMAB) today announced that over 20 abstracts evaluating epcoritamab-bysp (EPKINLY®), a subcutaneously administered T-cell engaging bispecific antibody, will be presented at the 66th Annual Meeting of the…
Immunis, Inc., a clinical-stage biotechnology company focused on developing innovative secretomes for age-related diseases and immune dysfunction, has launched non-terminal safety studies for canine muscle atrophy in collaboration with VetBio…
BlueWind Medical, Ltd., a leader in implantable Tibial Neuromodulation (iTNM) and developer of the Revi® System for treating urge urinary incontinence (UUI), announced that the Centers for Medicare & Medicaid…
Biomodal, an omics-based life sciences technology and analytics company, announced today that it will present new data showcasing the effectiveness of its duet multiomics solution, evoC, in the early detection…
AcariaHealth, a prominent national specialty pharmacy and part of Centene Corporation (NYSE: CNC), received multiple accolades at the 2024 National Association of Specialty Pharmacy (NASP) Annual Meeting held in Nashville,…
On FCS Awareness Day, Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced the launch of its new disease awareness campaign, “We’ll Get There Soon,” aimed at providing hope to the community affected…
KORU Medical Systems, Inc. (NASDAQ: KRMD), a prominent medical technology company specializing in innovative large-volume subcutaneous infusion solutions, recently shared data highlighting nursing preference for the KORU FreedomEdge® Infusion System…
Cofactor Genomics, Inc., a clinical-stage company focused on bridging the precision medicine gap through RNA decoding, has announced the appointment of Dr. Howard McLeod, Pharm.D., FASCO, FCCP, to its Advisory…
Elixir Medical, known for its innovative technologies in treating cardiovascular disease, has announced compelling late-breaking data showcasing the advantages of the DynamX® Coronary Bioadaptor System over the Resolute Onyx™ zotarolimus…
Cardiawave SA, the developer of the innovative Valvosoft Non-Invasive Ultrasound Therapy (NIUT) device for severe symptomatic calcific aortic stenosis (CAS), announced today that the device achieved its primary endpoint in…
Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving treatments for autoimmune and inflammatory diseases, announced that new translational data for its RIPK2 scaffolding inhibitor, OD-07656, will be presented…
Vertex Pharmaceuticals (Nasdaq: VRTX) has shared updates on its pipeline for kidney diseases, including IgA nephropathy (IgAN), primary membranous nephropathy (pMN), and APOL1-mediated kidney disease (AMKD). The updates highlight the…